Visit Our HIV Medicines
Find Medical Information organized by product. Explore now
CONGRESS PRESENTATIONS
EACS 2023
October 18-21, 2023
Warsaw, Poland
2023 Post Fall Conference
Scientific Engagement Webinar - with panel discussion
Dolutegravir-based Regimens
Cabotegravir Treatment
Cabotegravir Prevention
Fostemsavir
Wonderlich ER, et al.
Wonderlich ER, et al.
Pipeline
Leone P, et al.
Leone P, et al.
- Title
- Presenter Disclosure Information
- Introduction
- BANNER Study Design
- N6LS Led to Virologic Response in 13/14 Participants
- BANNER Demographics and Baseline Characteristics
- Safety Summary: Monotherapy Phase
- Summary of Drug-Related Adverse Events: Monotherapy Phase
- Summary of Infusion/Injection Site Reactions: Monotherapy Phase
- Conclusions
- Acknowledgments
- Disclaimer
Joshi SR, et al.
Joshi SR, et al.
Joshi SR, et al.
Joshi SR, et al.
Above Brand
O'Brien P, et al.
O'Brien P, et al.
- Title
- Presenter Disclosure Information
- Introduction
- Overview of the Disease Specific Programme (DSP)™
- Demographics and Baseline Characteristics
- There Were Some Differences in Perceptions of Treatment Satisfaction Between Physicians and People Living With HIV
- Physicians and People Living With HIV Highlighted Impact on HRQoL as Their Reason for Not Being Very Satisfied With Their Current ART
- Health Status Was Assessed Using the EQ-5D-5L, and HRQoL Was Assessed Using the HIV-Specific PozQoL Instrument
- HIV-Specific Instruments Are Needed to Fully Capture the Burden of HIV
- People Living With HIV Still Reported Mental Health Burdens Related to Their ART
- Physicians Highlighted the Important Role of Long-Acting Injectables to Address Key Issues With HIV Treatment
- Conclusions
- Acknowledgments
- Disclaimer
This content was acquired following an unsolicited medical information enquiry by a healthcare professional. Always consult the product information for your country, before prescribing a ViiV medicine. ViiV does not recommend the use of our medicines outside the terms of their license. In some cases, the scientific Information requested and downloaded may relate to the use of our medicine(s) outside of their license.
Are you a US healthcare provider?
This web portal is intended as an educational resource for healthcare providers practicing in the United States. It may include information about products or uses that have not been approved by the US Food and Drug Administration.
If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse.
Connect With Our Medical Experts
Find My ViiV MSL
Easily find the ViiV Medical Science Liaison (MSL) in your area.
Talk to a Medical Expert
Connect now with a live ViiV Medical Expert.
Request a Scientific Discussion
Submit a request for additional information from a ViiV Medical Expert.
Contact Us
Chat Live
Get immediate assistance from a ViiV Healthcare Professional.
Call 1‑888‑226‑8434
Weekdays from 8 AM to 6 PM ET
(5 AM – 3 PM PT)
Report an Adverse Event
To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at 1‑877‑844‑8872 or FDA at 1‑800‑332‑1088 or www.fda.gov/medwatch